Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG(L)-scFv)  (IGLFV-H295)

Recombinant Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD44 antibody are fused to the C terminus of an anti-CR3 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.

Datasheet